This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
F-star Alpha spins out of F-star GMBH; raises €9.4mm through Series A round
Austrian cancer company F-star GMBH has spun out some of its oncology assets into F-star Alpha Ltd. The new independent company concurrently raised €9.4mm ($12.9mm) through a Series A round from Atlas Venture, Asecap Venture, TVM Capital, SR One, MP Healthcare Venture Management, and MS Ventures (formerly Merck Serono Ventures). F-star Alpha’s first preclinical project in-licensed from its originator is FS102 for breast, gastric, and colorectal cancers.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?